Geniposide prevents rotenone-induced apoptosis in primary cultured neurons

@article{Li2015GeniposidePR,
  title={Geniposide prevents rotenone-induced apoptosis in primary cultured neurons},
  author={Lin Li and Juan Zhao and Ke Liu and Guang-lai Li and Yan Han and Yue-Ze Liu},
  journal={Neural Regeneration Research},
  year={2015},
  volume={10},
  pages={1617 - 1621},
  url={https://api.semanticscholar.org/CorpusID:5956811}
}
It is indicated that geniposide diminished rotenone-induced injury in primary neurons by suppressing apoptosis, which may be one of the molecular mechanisms underlying the efficacy of genipOSide in the treatment of neurodegenerative diseases.

Figures from this paper

Synergistic neuroprotective effects of Geniposide and ursodeoxycholic acid in hypoxia-reoxygenation injury in SH-SY5Y cells

The study indicates that the protective effects of GT on OGD/R-induced apoptosis in SH-SY5Y cells are associated with the inhibition of ERS and autophagy.

GLP-1’s role in neuroprotection: a systematic review

Based on the preclinical studies, GLP-1 modifying agents are promising targets for neuroprotection and further clinical trials are needed for a benchside to bedside translation of recent findings.

A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases

It is concluded that the release of geniposide is controlled by gel corrosion, and that the permeation of genipside is time-dependent, and the more residence time, mucoadhesive, thermoreversible in situ nasal gel of genIPoside for neurodegenerative diseases is of compliance and potential application.

Liraglutide improved the cognitive function of diabetic mice via the receptor of advanced glycation end products down-regulation

It is demonstrated that the cognitive function of diabetic mice was improved by liraglutide via the down-regulation of RAGE through the direct-interaction between RAGE and GLP-1R.

Geniposide regulates insulin-degrading enzyme expression to inhibit the cytotoxicity of Aβ₁₋₄₂ in cortical neurons.

The findings indicated that geniposide activating GLP-1R to against Aβ-induced neurotoxicity involved in its regulation on the expression of IDE in cortical neurons, which provided an additional mechanistic insight into the role of GLp-1r in neuroprotection.

Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway

It is demonstrated that the PI3K signaling pathway is involved in the neuroprotection of geniposide in PC 12 cells against the oxidative damage induced by H2O2 in PC12 cells.

Geniposide inhibits CoCl2-induced PC12 cells death via the mitochondrial pathway.

Geniposide protects PC12 cells from CoCl(2) involved in mitochondrial mediated apoptosis, and GLP-1R might play a critical role in the neuroprotection of geniposid in PC 12 cells.

The protective effect of geniposide on human neuroblastoma cells in the presence of formaldehyde

Results indicate that geniposide can protect SH-SY5Y cells against formaldehyde stress through modulating the expression of Bcl-2, P53, caspase 3 and caspases 9, and by increasing the activity of intracellular superoxide dismutase and glutathione peroxidase.

GLP-1 receptor plays a critical role in geniposide-induced expression of heme oxygenase-1 in PC12 cells

GLP-1R plays a critical role in geniposide-induced HO-1 expression to attenuate oxidative insults in PC12 cells.

Complex I Inhibitors Induce Dose‐Dependent Apoptosis in PC12 Cells: Relevance to Parkinson's Disease

Results suggest that both 1‐methyl‐4‐phenylpyridinium and rotenone cause apoptosis at low concentrations and necrosis at high concentrations, and this dose‐dependent shift in the mode of cell death induced by these mitochondrial toxins may have important implications for the mechanism of neuronal cell death in PD.

Geniposide Ameliorates Learning Memory Deficits, Reduces Tau Phosphorylation and Decreases Apoptosis via GSK3β Pathway in Streptozotocin‐Induced Alzheimer Rat Model

The study suggests that the water soluble and orally active monomer of Chinese herbal medicine geniposide may serve as a novel therapeutic agent for the treatment of sporadic AD.